FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOaktree Acquisition Corp. III Life Sciences
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OACCW
Oaktree Acquisition Corp. III Life Sciences Stock AnalysisComprehensive stock analysis for Oaktree Acquisition Corp. III Life Sciences (OACCW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOACCW
OACCW
Oaktree Acquisition Corp. III Life Sciences
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OACCW
  1. Home
  2. Stocks
  3. Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences

🇺🇸OACCW•NASDAQ

Oaktree Acquisition Corp. III Life Sciences

🇺🇸OACCW•NASDAQ
Market cap
$221.89M
Sentiment

Your view on OACCW

Mkt Cap
$221.89M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Oaktree Acquisition Corp. III Life Sciences

Industry
Shell Companies
Sector
Financial Services
CEO
Zaid Pardesi
Headquarters
333 South Grand Avenue, Los Angeles, CA, US
Industry
Shell Companies
Sector
Financial Services
CEO
Zaid Pardesi
Headquarters
333 South Grand Avenue, Los Angeles, CA, US
Description

Oaktree Acquisition Corp. III Life Sciences presently lacks significant commercial operations. Its primary focus is on completing a business combination, which could take the form of a merger, share exchange, asset acquisition, stock purchase, reorganization, or a similar corporate transaction, with one or more entities.

The company aims to identify and acquire businesses operating in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors across North America and Europe. Incorporated in 2024, its base of operations is in Los Angeles, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Oaktree Acquisition Corp. III Life Sciences from FRC's valuation model, read against the market price. OACCW last traded at $0.79, 58.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Oaktree Acquisition Corp. III Life Sciences. Starting points for Oaktree Acquisition Corp. III Life Sciences: P/E 58.4, EPS $0.23, beta 0.20 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Oaktree Acquisition Corp. III Life Sciences. Trailing twelve-month EPS for Oaktree Acquisition Corp. III Life Sciences stands at $0.23. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OACCW18 companies
Compare OACCW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • DRDBWRoman DBDR Acquisition Corp. IIFinancial - Conglomerates$180M
  • GPATWGP-Act III Acquisition Corp.Shell Companies$275M
  • LPAAWLaunch One Acquisition Corp.Shell Companies$77M
  • MACIWMelar Acquisition Corp. I WarrantShell Companies$210M
  • PLMKWPlum Acquisition Corp. IVShell Companies$222M
  • SIMAWSIM Acquisition Corp. IShell Companies$2M

More Shell Companies companies

  • ORIQWOrigin Investment Corp I Warrant.NASDAQ$1M
  • OTAIStarlink Ai Acquisition Corp.NYSE$136M
  • LPCVLaunchpad Cadenza Acquisition Corp I Class A Ordinary ShareNASDAQ$233M
  • LPCVULaunchpad Cadenza Acquisition Corp INASDAQ$235M
  • LPCVWLaunchpad Cadenza Acquisition Corp I WarrantNASDAQ$87M
  • LTGJXiamen Lutong International Travel Agency Co. Ltd.OTC$17,450
  • LTGRWLong Table Growth Corp. WarrantsNASDAQ$2M
  • LWACLightWave Acquisition Corp.NASDAQ$313M
  • LWACULightWave Acquisition Corp.NASDAQ$313M
  • LWACWLightWave Acquisition Corp.NASDAQ$158M
  • MACIMelar Acquisition Corp. INASDAQ$217M
  • MACIUMelar Acquisition Corp. INASDAQ$226M
Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Oaktree Acquisition Corp. III Life Sciences executives and directors. Shares of Oaktree Acquisition Corp. III Life Sciences have traded between $0.82 and $1.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Oaktree Acquisition Corp. III Life Sciences. Coverage tracks Oaktree Acquisition Corp. III Life Sciences within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Oaktree Acquisition Corp. III Life Sciences.

OACCW Analysis
Fair
Past4
Growth2
Health5
Profit1
Value1

News

Latest Market News